Verbeek, Wieke H.M.
~ 100  Ergebnisse:
Personensuche X
?
6

First-line everolimus and cisplatin in patients with advanc..:

Levy, Sonja ; Verbeek, Wieke H.M. ; Eskens, Ferry A.L.M....
Therapeutic Advances in Medical Oncology.  14 (2022)  - p. 175883592210770 , 2022
 
?
7

Cost-Effectiveness of Colorectal Cancer Surveillance in Hod..:

Ykema, Berbel L.M. ; Gini, Andrea ; Rigter, Lisanne S....
Cancer Epidemiology, Biomarkers & Prevention.  31 (2022)  12 - p. 2157-2168 , 2022
 
?
13

Clinicopathological features and risk factors for developin..:

Ykema, Berbel L.M ; Rigter, Lisanne S ; Spaander, Manon C.W...
Ykema , B L M , Rigter , L S , Spaander , M C W , Moons , L M G , Bisseling , T M , Aleman , B M P , Dekker , E , Verbeek , W H M , Kuipers , E J , de Boer , J P , Lugtenburg , P J , Janus , C P M , Petersen , E J , Roesink , J M , van der Maazen , R W M , Meijer , G A , Schaapveld , M , van Leeuwen , F E , Carvalho , B , Snaebjornsson , P & van Leerdam , M E 2022 , ' Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin's lymphoma survivors ' , Digestive Endoscopy , vol. 34 , no. 1 , pp. 163-170 . https://doi.org/10.1111/den.14004.  , 2022
 
?
14

First-Line everolimus and cisplatin in patients with advanc..:

Levy, Sonja ; Verbeek, Wieke H. M ; Eskens, Ferry A. L. M...
https://research.rug.nl/en/publications/3cfc5199-5ce0-4252-809e-d877d82b29b4.  , 2022
 
1-15